Zhengye Biotechnology Holding Ltd is a company mainly engaged in the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. The Company markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The Company owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The Company also engages in vaccines for treating livestock. The Company mainly conducts its business in the domestic market. The Company mainly conducts its business in the domestic and overseas market.
Unternehmens-codeZYBT
Name des UnternehmensZhengye Biotechnology Holding Ltd
IPO-datumJan 07, 2025
Gegründet am2023
CEOMr. Songlin Song
Anzahl der mitarbeiter275
WertpapierartOrdinary Share
GeschäftsjahresendeJan 07
AddresseNo.1 Lianmeng Street, Jilin Economic &
StadtJILIN
BörseNASDAQ Capital Market Consolidated
LandChina
Postleitzahl132101
Telefon
Websitehttps://www.jlzybio.com./
Unternehmens-codeZYBT
IPO-datumJan 07, 2025
Gegründet am2023
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten